Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study


AYDIN N. N., AKSOY F., Yavuz I., Iskender S., Yildirim A. A., YILDIZ İ. E., ...More

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.25, no.3, pp.105-108, 2019 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.4274/vhd.galenos.2019.2019.0025
  • Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.105-108
  • Keywords: Hepatitis C, hemodialysis, direct-acting antiviral agent, INFECTED PATIENTS, VIRUS-INFECTION, REGIMENS, KIDNEY, SAFETY, MANAGEMENT
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Objectives: Hepatitis C virus (HCV) infection is common among hemodialysis (HD) patients and is associated with increased morbidity and mortality. New generation direct-acting antiviral (DAA) agents are safe and effective in treatment HCV infection in HD patients. The aim of this a multi-center study was to assess the efficacy of DAAs in HD patients with HCV infection.